Smart Manufacturing For Pharmaceuticals: Enabling Agile Production With Modular Automation And MTP

If your pharma manufacturing operation is still running at the industry average of 35% overall equipment effectiveness (OEE), you're leaving a lot on the table. And that's before factoring in the pressure of shrinking patent windows, increasingly complex therapy portfolios, and regulatory scrutiny that doesn't let up.

The case for modular automation built on the Module Type Package (MTP) standard is compelling. MTP lets you swap in pre-validated equipment from different OEMs without rewriting control code, which matters enormously during tech transfers, scale-ups, or brownfield extensions. Real-world results cited here include up to 70% reduction in engineering effort and 50% faster plant scale-up. BioNTech cut brownfield conversion time by 50%; Bayer Bitterfeld modeled all automation processes in just three to six weeks.

Paperless manufacturing is the other piece most operations underestimate. Over 60% of drug shortages trace to production and quality failures, many rooted in paper-based processes prone to transcription errors and incomplete batch records. Electronic batch records (EBRs) combined with generative AI-assisted recipe creation address this directly.

The third pillar, IT/OT convergence, ties it together: real-time process analytical technology (PAT) monitoring, predictive maintenance, and FDA GMP compliance visibility all depend on it.

Download the full analysis to see how these three imperatives translate into a concrete smart manufacturing roadmap for your facility.